369 related articles for article (PubMed ID: 28164774)
1. Tauopathies - Focus on Changes at the Neurovascular Unit.
Michalicova A; Banks WA; Legath J; Kovac A
Curr Alzheimer Res; 2017; 14(7):790-801. PubMed ID: 28164774
[TBL] [Abstract][Full Text] [Related]
2. Tau Protein and Its Role in Blood-Brain Barrier Dysfunction.
Michalicova A; Majerova P; Kovac A
Front Mol Neurosci; 2020; 13():570045. PubMed ID: 33100967
[TBL] [Abstract][Full Text] [Related]
3. Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy.
Blair LJ; Frauen HD; Zhang B; Nordhues BA; Bijan S; Lin YC; Zamudio F; Hernandez LD; Sabbagh JJ; Selenica ML; Dickey CA
Acta Neuropathol Commun; 2015 Jan; 3():8. PubMed ID: 25775028
[TBL] [Abstract][Full Text] [Related]
4. Trafficking of immune cells across the blood-brain barrier is modulated by neurofibrillary pathology in tauopathies.
Majerova P; Michalicova A; Cente M; Hanes J; Vegh J; Kittel A; Kosikova N; Cigankova V; Mihaljevic S; Jadhav S; Kovac A
PLoS One; 2019; 14(5):e0217216. PubMed ID: 31120951
[TBL] [Abstract][Full Text] [Related]
5. Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.
Yamazaki Y; Kanekiyo T
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902142
[TBL] [Abstract][Full Text] [Related]
6. Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease.
Sagare AP; Bell RD; Zlokovic BV
J Alzheimers Dis; 2013; 33 Suppl 1(0 1):S87-100. PubMed ID: 22751174
[TBL] [Abstract][Full Text] [Related]
7. Neurovascular mechanisms of Alzheimer's neurodegeneration.
Zlokovic BV
Trends Neurosci; 2005 Apr; 28(4):202-8. PubMed ID: 15808355
[TBL] [Abstract][Full Text] [Related]
8. The pericyte: a forgotten cell type with important implications for Alzheimer's disease?
Winkler EA; Sagare AP; Zlokovic BV
Brain Pathol; 2014 Jul; 24(4):371-86. PubMed ID: 24946075
[TBL] [Abstract][Full Text] [Related]
9. Impact of Tau on Neurovascular Pathology in Alzheimer's Disease.
Canepa E; Fossati S
Front Neurol; 2020; 11():573324. PubMed ID: 33488493
[TBL] [Abstract][Full Text] [Related]
10. Brain Drug Delivery: Overcoming the Blood-brain Barrier to Treat Tauopathies.
Hanes J; Dobakova E; Majerova P
Curr Pharm Des; 2020; 26(13):1448-1465. PubMed ID: 32178609
[TBL] [Abstract][Full Text] [Related]
11. Mild chronic cerebral hypoperfusion induces neurovascular dysfunction, triggering peripheral beta-amyloid brain entry and aggregation.
ElAli A; Thériault P; Préfontaine P; Rivest S
Acta Neuropathol Commun; 2013 Nov; 1():75. PubMed ID: 24252187
[TBL] [Abstract][Full Text] [Related]
12. Human truncated tau is using a different mechanism from amyloid-beta to damage the blood-brain barrier.
Kovac A; Zilkova M; Deli MA; Zilka N; Novak M
J Alzheimers Dis; 2009; 18(4):897-906. PubMed ID: 19749439
[TBL] [Abstract][Full Text] [Related]
13. The blood-brain barrier in Alzheimer's disease.
Zenaro E; Piacentino G; Constantin G
Neurobiol Dis; 2017 Nov; 107():41-56. PubMed ID: 27425887
[TBL] [Abstract][Full Text] [Related]
14. Locus Coeruleus and neurovascular unit: From its role in physiology to its potential role in Alzheimer's disease pathogenesis.
Giorgi FS; Galgani A; Puglisi-Allegra S; Limanaqi F; Busceti CL; Fornai F
J Neurosci Res; 2020 Dec; 98(12):2406-2434. PubMed ID: 32875628
[TBL] [Abstract][Full Text] [Related]
15. Seizure-induced microvascular injury is associated with impaired neurovascular coupling and blood-brain barrier dysfunction.
Prager O; Kamintsky L; Hasam-Henderson LA; Schoknecht K; Wuntke V; Papageorgiou I; Swolinsky J; Muoio V; Bar-Klein G; Vazana U; Heinemann U; Friedman A; Kovács R
Epilepsia; 2019 Feb; 60(2):322-336. PubMed ID: 30609012
[TBL] [Abstract][Full Text] [Related]
16. The blood-brain barrier in health and chronic neurodegenerative disorders.
Zlokovic BV
Neuron; 2008 Jan; 57(2):178-201. PubMed ID: 18215617
[TBL] [Abstract][Full Text] [Related]
17. The impact of neurovascular, blood-brain barrier, and glymphatic dysfunction in neurodegenerative and metabolic diseases.
Braun M; Iliff JJ
Int Rev Neurobiol; 2020; 154():413-436. PubMed ID: 32739013
[TBL] [Abstract][Full Text] [Related]
18. Amyloid Beta-Mediated Neurovascular Toxicity in Alzheimer's Disease.
Banerjee S; Banerjee S
Methods Mol Biol; 2024; 2761():355-372. PubMed ID: 38427250
[TBL] [Abstract][Full Text] [Related]
19. Neurovascular Unit Dysfunction and Neurodegenerative Disorders.
Yu X; Ji C; Shao A
Front Neurosci; 2020; 14():334. PubMed ID: 32410936
[TBL] [Abstract][Full Text] [Related]
20. New therapeutic targets in the neurovascular pathway in Alzheimer's disease.
Zlokovic BV
Neurotherapeutics; 2008 Jul; 5(3):409-14. PubMed ID: 18625452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
